Medical and Pharmaceutical Against the rise of early onset cancer: a Mugglehead roundup Cancer treatment markets are set to expand rapidly over the next decade Joseph Morton4 hours ago
Medical and Pharmaceutical Lucid Diagnostics joins Russell 2000 and 3000 indexes Investment managers and institutional investors widely use the Russell indexes for both index funds and active investment benchmarks Joseph Morton2 days ago
Medical and Pharmaceutical Phase Scientific International advances urine biopsy tech with $34M fundraising round The company has gained strong market traction by launching over 30 diagnostic products across multiple health categories Joseph Morton3 days ago
Medical and Pharmaceutical Prenetics Global shares spike on significant revenue developments The company projects 2025 revenue to range between USD$73 million and USD$85 million Joseph MortonMay 22, 2025
Medical and Pharmaceutical BioMark Diagnostics reveals AI breakthrough in early lung cancer detection The model uses graph neural networks to interpret complex biological interactions Joseph MortonMay 20, 2025
AI and Autonomy Ainos introduces breath sensing equipment to robots in Japan System digitizes and identifies a wide range of volatile organic compounds (VOC), which are compiled into a SmellID Joseph MortonApril 23, 2025
Medical and Pharmaceutical Smokers skipping lung cancer screenings: study Lung cancer remains the leading cause of cancer death in the United States Joseph MortonApril 10, 2025
Health & Wellness Scientists develop breath-related diagnostic tool for early detection for silicosis The test combines mass spectrometry with AI to quickly detect silicosis from breath samples Joseph MortonMarch 24, 2025
Medical and Pharmaceutical Poor people die of cancer more than rich: UK research Nearly half of the 28,400 additional cancer deaths linked to deprivation are due to lung cancer Joseph MortonFebruary 24, 2025
Medical and Pharmaceutical New Korean cancer tech finds mutations with only a few drops of blood In a clinical trial with blood from 83 patients, the test identified 100 per cent of EGFR gene mutations Joseph MortonFebruary 18, 2025